{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:45:43Z","timestamp":1776494743520,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.drup.2024.101172","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T13:36:21Z","timestamp":1731504981000},"page":"101172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Pei-Yao","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.drup.2024.101172_bib1","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.drup.2024.101172_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41467-020-20731-x","article-title":"Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.drup.2024.101172_bib3","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S2214-109X(18)30452-2","article-title":"Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study","volume":"7","author":"Harris","year":"2019","journal-title":"Lancet Glob. Health"},{"issue":"5","key":"10.1016\/j.drup.2024.101172_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012306","article-title":"Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study","volume":"8","author":"Mao","year":"2023","journal-title":"BMJ Glob. Health"},{"issue":"6","key":"10.1016\/j.drup.2024.101172_bib5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2024.101172_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00131-9","article-title":"The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis","author":"Pei","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.drup.2024.101172_bib7","series-title":"It\u2019s Time to End Drug-Resistant Tuberculosis: The Case for Action","author":"The Economist Intelligence","year":"2019"},{"issue":"1","key":"10.1016\/j.drup.2024.101172_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12916-021-01932-7","article-title":"The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China","volume":"19","author":"Weerasuriya","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.drup.2024.101172_bib9","series-title":"Global Tuberculosis Report 2023","author":"WHO","year":"2023"},{"issue":"1","key":"10.1016\/j.drup.2024.101172_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-020-01545-6","article-title":"Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis","volume":"18","author":"Yang","year":"2020","journal-title":"BMC Med."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T19:48:04Z","timestamp":1734205684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"alternative-id":["S1368764624001304"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101172","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101172"}}